$180 Million is the total value of Omega Fund Management, LLC's 10 reported holdings in Q4 2015. The portfolio turnover from Q3 2015 to Q4 2015 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JUNO | Sell | Juno Therapeutics | $54,062,000 | -0.1% | 1,229,512 | -7.5% | 30.09% | -1.2% |
| PRTK | Paratek Pharmaceuticals | $40,574,000 | -0.2% | 2,138,872 | 0.0% | 22.58% | -1.3% | |
| EGLTQ | Buy | Egalet | $31,021,000 | -11.0% | 2,814,928 | +6.4% | 17.26% | -12.1% |
| FGEN | Sell | FibroGen | $25,052,000 | +31.0% | 822,175 | -5.7% | 13.94% | +29.5% |
| NBRV | Nabriva Therapeuticssponsored adr | $11,023,000 | +1.3% | 1,145,890 | 0.0% | 6.14% | +0.1% | |
| PIRS | Pieris Pharmaceuticals | $5,688,000 | +25.1% | 2,483,949 | 0.0% | 3.17% | +23.7% | |
| ESSA Pharma | $4,636,000 | -32.7% | 1,090,909 | 0.0% | 2.58% | -33.4% | ||
| PRTO | Proteon Therapeutics | $3,878,000 | +11.5% | 250,000 | 0.0% | 2.16% | +10.2% | |
| DRNA | Dicerna Pharmaceuticals | $2,652,000 | +44.5% | 223,457 | 0.0% | 1.48% | +42.9% | |
| CBAY | CymaBay Therapeutics | $1,099,000 | -12.8% | 650,000 | 0.0% | 0.61% | -13.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-02-10
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Paratek Pharmaceuticals, Inc. | 34 | Q1 2023 | 39.1% |
| FibroGen, Inc. | 28 | Q3 2021 | 14.3% |
| Jounce Therapeutics | 25 | Q1 2023 | 11.6% |
| Pieris Pharmaceuticals | 23 | Q1 2021 | 5.2% |
| Replimune Group | 21 | Q3 2023 | 47.2% |
| Cidara Therapeutics | 20 | Q3 2021 | 5.8% |
| Morphic Holding | 18 | Q3 2023 | 22.0% |
| Immunic Inc | 18 | Q3 2023 | 9.0% |
| Dicerna Pharmaceuticals | 18 | Q1 2019 | 3.7% |
| Egalet | 17 | Q4 2018 | 19.6% |
View Omega Fund Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| 13F-HR/A | 2021-11-15 |
View Omega Fund Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.